Streamlining Dermatology AIM Specialty Health Integration for Enhanced PA Efficiency

Navigating prior authorizations for high-cost biologics and complex procedures in dermatology demands robust systems, and Klivira delivers streamlined **dermatology AIM Specialty Health integration** capabilities to enhance efficiency.

Dermatology practices face unique prior authorization challenges, from managing chronic biologic therapies to complex surgical procedures like Mohs. While specialty benefit managers such as AIM Specialty Health often oversee specific service categories, the need for comprehensive integration with diverse payer systems is universal. Klivira's platform provides the critical connectivity to navigate these complexities, ensuring a consistent and efficient PA workflow for your dermatology services.

The Prior Authorization Imperative in Dermatology

Dermatology prior authorizations are concentrated in high-cost categories like biologics for psoriasis, psoriatic arthritis, atopic dermatitis (e.g., Dupixent, Cosentyx, Tremfya, Skyrizi), and hidradenitis suppurativa. Additionally, procedures like Mohs micrographic surgery for non-melanoma skin cancers frequently trigger PA requirements. Efficient management of these PAs is critical for patient access and revenue integrity.

Navigating Specialty Benefit Managers (SBMs) in Your Dermatology Workflow

Specialty benefit managers like AIM Specialty Health (part of Carelon/Elevance) are commonly used by payers to manage prior authorizations for specific high-cost services, such as radiology, cardiology, and musculoskeletal care. While AIM's primary focus may be in other specialties, dermatology practices require robust integration capabilities to handle the diverse range of payer and SBM requirements they encounter. Klivira's platform ensures your practice can efficiently process PAs, regardless of the specific delegated entity involved.

Key Dermatology PA Triggers and Documentation Requirements

**Biologics:** For conditions like psoriasis and atopic dermatitis, requiring documentation of diagnosis (PASI/BSA, EASI/SCORAD scores), prior topical/phototherapy/conventional systemic therapy trials, and pre-biologic screenings (TB, hepatitis).
**Mohs Micrographic Surgery:** Payer policies often require adherence to AAD Appropriate Use Criteria, documenting tumor type, site (cosmetically/functionally sensitive areas), and any prior treatments.
**Advanced Skin Cancer Treatments:** Immunotherapies for melanoma (e.g., Keytruda, Opdivo) and targeted therapies require detailed clinical justification.
**Phototherapy:** Especially for home phototherapy, documentation of prior topical therapy trials is often required.
**Periodic Re-authorization:** Chronic biologic treatments necessitate re-authorization cycles (e.g., 6/12 months), requiring updated severity scores and continued medical necessity.

Klivira's Solution for Dermatology Prior Authorization

Klivira's platform is designed to streamline dermatology prior authorizations by incorporating AAD-guideline-aware step-therapy logic for biologics and AUC validation for Mohs surgery. We automate the periodic re-authorization workflow for chronic treatments and intelligently route medical-vs-pharmacy benefit PAs. This targeted approach helps dermatology practices reduce administrative burden and accelerate patient access to critical therapies.

Seamless Integration with Payers and EMRs for Dermatology Services

Klivira provides comprehensive integration capabilities, connecting your EMR system with various payer channels, including X12 278 transactions and direct payer portal automation. For dermatology practices, this means a unified workflow regardless of whether the PA is handled directly by the payer or a specialty benefit manager. Our platform streamlines data exchange, reducing manual entry and potential errors across your entire prior authorization ecosystem.

Addressing Common Dermatology PA Denials Proactively

Many dermatology PA denials stem from issues like non-compliance with step therapy protocols for biologics, lack of documented disease severity (e.g., missing PASI/EASI scores), or Mohs AUC mismatches. Klivira's intelligent workflows prompt for required documentation, validate against payer policies and clinical guidelines, and flag potential issues before submission, significantly reducing denial rates and appeals.

Frequently asked questions

How does Klivira handle re-authorization for chronic dermatology biologics?

Klivira's platform incorporates automated workflows for periodic re-authorization of chronic biologic treatments. It tracks re-authorization cycles, prompts for necessary updated clinical documentation (e.g., disease severity scores), and facilitates timely submission to ensure continuity of care for your dermatology patients.

Can Klivira integrate with my EMR for dermatology PA workflows?

Yes, Klivira offers robust EMR integration capabilities, allowing for seamless data exchange between your electronic medical record system and our prior authorization platform. This minimizes manual data entry, reduces errors, and ensures that clinical documentation required for dermatology PAs is readily available.

What specific dermatology procedures or drugs commonly require prior authorization?

In dermatology, prior authorizations are frequently required for high-cost biologics (such as Dupixent, Cosentyx, Tremfya, Skyrizi), certain specialty topicals, and procedures like Mohs micrographic surgery. Advanced skin cancer treatments and specific phototherapy regimens can also trigger PA requirements.

How does Klivira help address common denial reasons for dermatology PAs?

Klivira's system proactively addresses common dermatology PA denials by guiding users through step-therapy requirements, validating documentation against AAD guidelines and Mohs AUC, and ensuring all necessary clinical information (e.g., PASI/EASI scores, screening results) is included before submission, reducing the likelihood of denials.

Does Klivira support both medical and pharmacy benefit PAs for dermatology?

Yes, Klivira is equipped to manage prior authorizations for both medical and pharmacy benefits relevant to dermatology. Our platform intelligently routes requests based on the specific drug or procedure, ensuring compliance with payer-specific requirements whether the service falls under the medical or pharmacy benefit.